CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection

Journal of Virology

Volumn 83, Issue 9, 2009, Pages 4700-4703

  Stuller, Kathleen A ^a   Flaño, Emilio ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; GAMMAHERPESVIRUS INFECTION 68; HERPES VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; MICE; PHENOTYPE;

MURINAE; MUS;

EID: 66149136771     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02240-08     Document Type: Article

References (19)

1. Adhikary, D., U. Behrends, A. Moosmann, K. Witter, G. W. Bornkamm, and J. Mautner. 2006. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J. Exp. Med. 203:995-1006.
2. + CTLs ex vivo. J. Immunol. 168:5954-5958.
3. Betts, M. R., and R. A. Koup. 2004. Detection of T-cell degranulation: CD107a and b. Methods Cell Biol. 75:497-512.
4. + T lymphocytes with cellular maturation. J. Exp. Med. 203:2865-2877.
5. + T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proc. Natl. Acad. Sci. USA 96:5135-5140.
6. + T cell function during viral persistence. J. Immunol. 179:141-153.
7. Jellison, E. R., S. K. Kim, and R. M. Welsh. 2005. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 174:614-618.
8. +. Proc. Natl. Acad. Sci. USA 79:2365-2369.
9. Landais, E., X. Saulquin, E. Scotet, L. Trautmann, M. A. Peyrat, J. L. Yates, W. W. Kwok, M. Bonneville, and E. Houssaint. 2004. Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood 103:1408-1416.
10. + T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J. Virol. 79:4896-4907.
11. McClellan, J. S., S. A. Tibbetts, S. Gangappa, K. A. Brett, and H. W. Virgin IV. 2004. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency. J. Virol. 78:6836-6845. (Pubitemid 38781521)
12. Misko, I. S., J. H. Pope, R. Hutter, T. D. Soszynski, and R. G. Kane. 1984. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int. J. Cancer 33:239-243. (Pubitemid 14184413)
13. + Th1 cells kill Burkitt's lymphoma cells. J. Immunol. 169:1593-1603.
14. Sparks-Thissen, R. L., D. C. Braaten, K. Hildner, T. L. Murphy, K. M. Murphy, and H. W. Virgin IV. 2005. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNγ. Virology 338:201-208.
15. Sparks-Thissen, R. L., D. C. Braaten, S. Kreher, S. H. Speck, and H. W. Virgin IV. 2004. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 78:6827-6835. (Pubitemid 38781520)
16. + T cell response during acute and persistent murine gamma-herpesvirus infection. Eur. J. Immunol. 29:1059-1067.
17. Su, Z., M. V. Peluso, S. H. Raffegerst, D. J. Schendel, and M. A. Roskrow. 2001. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. Eur. J. Immunol. 31:947-958. (Pubitemid 32237131)
18. dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens. Eur. J. Immunol. 31:2512-2520.
19. +, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection. Blood 103:2238-2247.